The Development of an Images Detection System Based on Extracting the Colour Gradient Co-occurrence Matrix Features

Aljarf, Ahd; Amin, Saad; Filippas, John; Shuttelworth, James

doi:10.1109/dese.2016.55

Cited by 2 publications

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The data obtained from Web of Science were converted to txt format and imported into CiteSpace V5.5.R1 SE, 64-bit (Drexel University, Philadelphia, PA, USA) and the Online Analysis Platform of Literature Metrology ( http://bibliometric.com/ ) for subsequent bibliometric analysis. The data downloaded from PubMed were uploaded to Bibliographic Item co-occurrence Matrix Builder (BICOMB), a tool for hotspot analysis [ 11 ].…”

Section: Methodsmentioning

confidence: 99%

A 10-year bibliometric analysis of osteosarcoma and cure from 2010 to 2019

Tao

Meng

et al. 2021

BMC Cancer

View full text Add to dashboard Cite

Background In recent decades, the 5-year survival rate of osteosarcoma remains poor, despite the variety of operations, and exploration of drug therapy has become the key to improvement. This study investigates the contribution of different aspects in osteosarcoma and cure, and predicts research hotspots to benefit future clinical outcomes. Methods The Web of Science and PubMed databases were queried to collect all relevant publications related to osteosarcoma and cure from 2009 to 2019. These data were imported into CiteSpace and the Online Analysis Platform of Literature Metrology for bibliometric analysis. Bi-clustering was performed on Bibliographic Item co-occurrence Matrix Builder (BICOMB) and gCLUTO to identify hotspots. Additionally, completed clinical trials on osteosarcoma with results past phase II were collated. Results A total of 2258 publications were identified in osteosarcoma and cure from 2009 to 2019. China has the largest number of publications (38.49%), followed by the United States (23.03%) with the greatest impact (centrality = 0.44). The centrality of most institutions is < 0.1, and Central South University and Texas MD Anderson Cancer Center possess the highest average citation rates of 3.25 and 2.87. BMC cancer has the highest average citation rate of 3.26 in 772 journals. Four authors (Picci P, Gorlick R, Bielack SS and Bacci G) made the best contributions. We also identified eight hotspots and collected 41 clinical trials related to drug research on osteosarcoma. Conclusions The urgent need exists to strengthen global academic exchanges. Overcoming multidrug resistance in osteosarcoma is the focus of past, present and future investigations. Transformation of the metastasis pattern, microenvironment genetics mechanism, alternative methods of systemic chemotherapy and exploration of traditional Chinese medicine is expected to contribute to a new upsurge of research.

show abstract

Section: Methodsmentioning

confidence: 99%